Purdue Pharma Says Opioid Settlement Talks Are Not Over

Purdue Pharma, the maker of Oxycontin, is considering filing for bankruptcy instead of settling numerous opioid lawsuits. The company believes a settlement is more beneficial to the public than prolonged litigation. However, negotiations with the Sackler family, who own Purdue, have stalled, as they declined to pay billions in compensation. Bankruptcy has been considered since March, with nearly 2000 lawsuits consolidated for a trial in October. The pressure is mounting for Purdue and other drugmakers to reach a settlement.

What new insight or understanding did you gain from this video?